Observations on intravenous administration of lignocaine in patients with myocardial infarction

Br Heart J. 1978 Dec;40(12):1371-5. doi: 10.1136/hrt.40.12.1371.

Abstract

Lignocaine was administered intravenously to 36 patients with acute myocardial infarction. A bolus of 100 mg followed by an infusion of 2 mg/minute failed to maintain plasma levels above 2 microgram/ml. A bolus of 100 mg followed by 4 mg/minute also failed to maintain satisfactory plasma concentrations during the first hour of therapy. A bolus of 75 mg was combined with an infusion of 10 mg/minute for 20 minutes followed by 1.5 mg/minute. Satisfactory plasma concentrations during the first hour were observed in 94 per cent of the estimations. No important adverse side effects occurred during the infusion of 10 mg/minute.

MeSH terms

  • Arrhythmias, Cardiac / complications
  • Arrhythmias, Cardiac / drug therapy*
  • Female
  • Humans
  • Infusions, Parenteral
  • Lidocaine / administration & dosage*
  • Lidocaine / blood
  • Lidocaine / therapeutic use
  • Male
  • Middle Aged
  • Myocardial Infarction / complications
  • Myocardial Infarction / drug therapy

Substances

  • Lidocaine